Zobrazeno 1 - 10
of 46
pro vyhledávání: '"hypoxia-ischemia encephalopathy"'
Autor:
Nhi T. Tran, Anna M. Muccini, Nadia Hale, Mary Tolcos, Rod J. Snow, David W. Walker, Stacey J. Ellery
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 17 (2023)
BackgroundCreatine supplementation during pregnancy is a promising prophylactic treatment for perinatal hypoxic brain injury. Previously, in near-term sheep we have shown that fetal creatine supplementation reduces cerebral metabolic and oxidative st
Externí odkaz:
https://doaj.org/article/86bcb721944c4d149e78d5ef9ed51d89
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Judy Seesahai, Maureen Luther, Paige Terrien Church, Patricia Maddalena, Elizabeth Asztalos, Thomas Rotter, Rudaina Banihani
Publikováno v:
Systematic Reviews, Vol 10, Iss 1, Pp 1-13 (2021)
Abstract Background The General Movements Assessment is a non-invasive and cost-effective tool with demonstrated reliability for identifying infants at risk for cerebral palsy. Early detection of cerebral palsy allows for the implementation of early
Externí odkaz:
https://doaj.org/article/e2bd1143b1e348319d4bbdbb64f768c8
Autor:
Judy Seesahai, Maureen Luther, Carmen Cindy Rhoden, Paige Terrien Church, Elizabeth Asztalos, Rudaina Banihani
Publikováno v:
Systematic Reviews, Vol 9, Iss 1, Pp 1-8 (2020)
Abstract Background Prediction of long-term neurodevelopmental outcomes remains an elusive goal for neonatology. Clinical and socioeconomic markers have not proven to be adequately reliable. The limitation in prognostication includes those term and l
Externí odkaz:
https://doaj.org/article/a45e0c7e4c314aaa9df715faeb7f903c
Autor:
Mariana Baserga, Tara L. DuPont, Betsy Ostrander, Stephen Minton, Mark Sheffield, Alfred H. Balch, Timothy M. Bahr, Kevin M. Watt
Publikováno v:
Frontiers in Pain Research, Vol 2 (2021)
Background: Neonatal hypoxia-ischemia encephalopathy (HIE) is the leading cause of neonatal death and poor neurodevelopmental outcomes worldwide. Therapeutic hypothermia (TH), while beneficial, still leaves many HIE treated infants with lifelong disa
Externí odkaz:
https://doaj.org/article/d12824e3e8ed4b25bfa6fae1b72c7806
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rudaina Banihani, Elizabeth Asztalos, Paige Church, Carmen Cindy Rhoden, Judy Seesahai, Maureen Luther
Publikováno v:
Systematic Reviews, Vol 9, Iss 1, Pp 1-8 (2020)
Systematic Reviews
Systematic Reviews
Background Prediction of long-term neurodevelopmental outcomes remains an elusive goal for neonatology. Clinical and socioeconomic markers have not proven to be adequately reliable. The limitation in prognostication includes those term and late-prete
Autor:
Rudaina Banihani, Elizabeth Asztalos, Patricia Maddalena, Maureen Luther, Judy Seesahai, Paige Church, Thomas Rotter
Publikováno v:
Systematic Reviews
Systematic Reviews, Vol 10, Iss 1, Pp 1-13 (2021)
Systematic Reviews, Vol 10, Iss 1, Pp 1-13 (2021)
BackgroundThe General Movements Assessment is a non-invasive and cost-effective tool with demonstrated reliability for identifying infants at risk for cerebral palsy. Early detection of cerebral palsy allows for the implementation of early interventi
Autor:
Avila Ruiz, Jhosep Enmanuel
Publikováno v:
Kurinczuk JJ, White-Koning M BN. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev Jun. 2010;86(6):329–38.
Prevention CC for DC and. CDC Grand Rounds: public health approaches to reducing U.S. infant mortality. MMWR MorbMortal Wkly Rep. 2013;62(31):628–28.
V. Alvarez; S. Guzmán CM. Análisis de Situación de Salud (ASIS) Colombia, 2016. Dir Epidemiol y Demogr Minist Salud y Protección Soc. :1–163.
Ahearne CE. Short and long term prognosis in perinatal asphyxia: An update. World J Clin Pediatr. 2016;5(1):67.
Al. RV et. Systematic Review of Biomarkers of Brain Injury in Term Neonatal Encephalopathy. Pediatr Neurol. 2009;40:215–26.
Salud. OOM de la. Estadísticas Sanitarias Mundiales 2013: Una Mina de Información sobre Salud Publica. 2013
Social EM protección. Analisis de la situación de salud Colombia ASIS. Minist Protección Soc. 2015
Mir I CL. Serum Biomarkers to evaluate the integrity of the neurovascular unit. Early Hum Dev. 2009;90(10):707–11.
Jacon J. KM et al. Etiologies of NICY deaths. Pediatrics. 2015;135(1):776–8.
Sarnat HB SM. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976;33:696–705.
Ennen CS, Huisman TA, Savage WJ, Northington FJ, Jennings JM, Everett AD et al. Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling. Am J Obs Gynecol. 2011;205(3):251–7.
Barkovich AJ, Miller SP, Bartha A et al. MRimaging,MRspectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy. AJNR Am J Neuroradiol. 2006;27:533-47.
Ramaswamy V, Horton J, Vandermeer B, Buscemi N, Miller S YJ. Systematic reviewof biomarkers of brain injury in term neonatal encephalopathy. Pediatr NeurolMar. 2009;40(3):215–26.
Shankaran S, Laptook AR, Ehrenkranz RA et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005;353:1574–84.
Savman K, Blennow M, Gustafson K, Tarkowski E HH. Cytokine response incerebrospinal fluid after birth asphyxia. Pedia Res Jun. 1998;43(6):746–51.
Imran N CL. Serum Biomarkers to evaluate the integrity of the neurovascular unit. Ear Hum Devel. 2014;90(10):707–11.
Mir IN, Steven Brown L, Rosenfeld CR CL. Placental clearance/synthesis of neurobiomarkers GFAP and UCH-L1 in healthy term neonates and those with moderate-severe neonatal encephalopathy. Pediatr Res. 2019
Douglas-Escobar M, Yang C, Bennett J, Shuster J, Theriaque D, Leibovici A et al. A pilot study of novel biomarkers in neonates with hypoxic-ischemic encephalopathy. Pediatr Res Dec. 2010;68(6):531–6.
Celtik C, Acunas B, Oner N PO. Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy. Brain Dev. 2004;26(6):398–402.
Thornberg E, Thiringer K, Hagberg H KI. Neuron specific enolase in asphyxiated newborns: association with encephalopathy and cerebral function monitor trace. Arch Dis Child Fetal Neonatal. 1995;72:39–42.
Gazzolo D, Marinoni E, Di Iorio R, Bruschettini M, Kornacka M, Lituania M et al. Urinary S100B protein measurements: A tool for the early identification of hypoxic-ischemic encephalopathy in asphyxiated full-term infants. Crit Care Med Jan. 2004;32(1):131–6.
Risso FM, Serpero LD, Zimmermann LJ, GavilanesAW, Frulio R, Michetti F et al. Urine S100 BB and A1B dimers are valuable predictors of adverse outcome in full-term asphyxiated infants. Acta Paediatr. 2013;102(10):e467-72.
Hu J, Ferreira A VEL. S100b induces neuronal death through nitric oxide reléase from astrocytes. J Neurochem. 1997;69:2294–301.
Murray DM. Biomarkers in neonatal hypoxic-ischemic encephalopathy-Review of the literature to date and future directions for research. hand clin neurol. 2019;162:281–93.
Sistema General de Seguridad Social en Salud M de S y de la PS. Republica de Colombia. Resolucion 8430 de 1993. Republica Ministerio de Salud. 1993. p. 1–19.
Welch V, Petticrew M, Tugwell P, Moher D, Neill JO, Waters E, et al. Extensión PRISMA-Equidad 2012 : guías para la escritura y la publicación de revisiones sistemáticas enfocadas en la equidad en salud *. Rev Panam Salud Pública. 2013;34(4):60–8.
Bersani I, Ferrari F, Lugli L, Ivani G, Conio A, Moataza B, Aboulgar H, Mufeed H, Iskander I, Kornacka M, Gruzfeld D, Dotta A, Savarese I CN et al. Monitoring the effectiveness of hypothermia in perinatal asphyxia infants by urinary S100B levels. Clin Chem Lab Med. 2019
Massaro AN1, Wu YW, Bammler TK, Comstock B, Mathur A, McKinstry RC, Chang T, Mayock DE MS et al. Plasma Biomarkers of Brain Injury in Neonatal Hypoxic-Ischemic Encephalopathy. J Pediatr. 2018
Alshweki A, Pérez-Muñuzuri A, López-Suárez O, Baña A CM. Relevance of urinary S100B protein levels as a short-term prognostic biomarker in asphyxiated infants treated with hypothermia. Med. 2017
Zaigham M, Lundberg F OP. Protein S100B in umbilical cord blood as a potential biomarker of hypoxic-ischemic encephalopathy in asphyxiated newborns. Early Hum Dev. 2017
Gazzolo D, Pluchinotta F, Bashir M, Aboulgar H, Said HM, Iman I, Ivani G, Conio A, Tina LG NF. Neurological abnormalities in full-term asphyxiated newborns and salivary S100B testing: the “Cooperative Multitask against Brain Injury of Neonates” (CoMBINe) international study. PLoS One. 2015
Chaparro-Huerta V, Flores-Soto ME, Merin Sigala ME, Barrera de León JC, Lemus-Varela ML, Torres-Mendoza BM B-ZC. Proinflammatory Cytokines, Enolase and S-100 as Early Biochemical Indicators of Hypoxic-Ischemic Encephalopathy Following Perinatal Asphyxia in Newborns. Pediatr Neonatol. 2017
Arca G, Arnaez J, Agut T, Núñez C, Stephan-Otto C, Valls A G-AA. Neuron-specific enolase is correlated with lesion topology, relative infarct volume and outcome of symptomatic NAIS. Arch Dis Child Fetal Neonatal Ed. 2020
JuanArnaezPhD CME-P ;Thais A. Neuron-Specific Enolase in Cerebrospinal Fluid Predicts Brain Injury After Sudden Unexpected Postnatal Collapse. Pediatr Neurol. 2019
Leifsdottir K1, 2, Mehmet H3, 4, Eksborg S1 HE. Fas-ligand and interleukin-6 in the cerebrospinal fluid are early predictors of hypoxic-ischemic encephalopathy and long-term outcomes after birth asphyxia in term infants. J Neuroinflammation. 2018
Patil UP, Mally PV WE. Serum biomarkers of neuronal injury in newborns evaluated for selective head cooling: a comparative pilot study. J Perinat Med. 2018
Ann-Marie Looney, Caroline Ahearne, Geraldine B. Boylan and DMM. Glial Fibrillary Acidic Protein Is Not an Early Marker of Injury in Perinatal Asphyxia and Hypoxic–Ischemic Encephalopathy. Front Neurol. 2015
Looney AM, O’Sullivan MP, Ahearne CE, Finder M, Felderhoff-Mueser, Boylan GB, Hallberg B MD. Altered Expression of Umbilical Cord Blood Levels of miR-181b and Its Downstream Target mUCH-L1 in Infants with Moderate and Severe Neonatal Hypoxic-Ischaemic Encephalopathy. Mol Neurobiol.
Kelen D, Andorka C, Szabó M1, Alafuzoff A Kaila K SM. Serum copeptin and neuron specific enolase are markers of neonatal distress and long-term neurodevelopmental outcome. PLoS One.
CE A. Short and long term prognosis in perinatal asphyxia: An update. World J Clin Pediatr. 2016;5(1):67.
Ahearne CE, Chang RY, Walsh BH, Boylan GB MD. Cord Blood IL-16 Is Associated with 3-Year Neurodevelopmental Outcomes in Perinatal Asphyxia. Dev Neurosci. 2017
Orrock JE, Panchapakesan K, Vezina G, Chang T, Harris K, Wang Y, Knoblach S MA. Association of brain injury and neonatal cytokine response during therapeutic hypothermia in newborns with hypoxic-ischemic encephalopathy. Pediatr Res. 2016
González-Losada, Cristóbal; Dorta-Contreras AJ. Marcadores moleculares de la asfixia perinatal / Molecular markers of perinatal asphyxia. Rev Cuba pediatr. 2018
Chalak Lina. Inflammatory Biomarkers Of Bith Asphyxia. Clin Perinatol. 2016; 43:501-510
Murray Dm. Biomarkers in neonatal hypoxic-ischemic encephalopathy-Review of the literature to date and future directions for research. Handb Clin Neurol. 2019;162:281-293.
González-Losada, Cristóbal; Dorta-Contreras, Alberto Juan. Marcadores moleculares de la asfixia perinatal / Molecular markers of perinatal asphyxia. Rev. cuba. Pediatr. 2018;90 (1)
Fisher P. In search of biomarkers for HIE. J. Pediatr. 2018: 194 (3).
Massaro A, Wu Y, Bammler T, Comstock B. Plasma Biomarkers Of Brain Injury in Neonatal Hypoyc –Ischemic Encephalopaty. J. Pediatric;2018: 194 (68)
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Prevention CC for DC and. CDC Grand Rounds: public health approaches to reducing U.S. infant mortality. MMWR MorbMortal Wkly Rep. 2013;62(31):628–28.
V. Alvarez; S. Guzmán CM. Análisis de Situación de Salud (ASIS) Colombia, 2016. Dir Epidemiol y Demogr Minist Salud y Protección Soc. :1–163.
Ahearne CE. Short and long term prognosis in perinatal asphyxia: An update. World J Clin Pediatr. 2016;5(1):67.
Al. RV et. Systematic Review of Biomarkers of Brain Injury in Term Neonatal Encephalopathy. Pediatr Neurol. 2009;40:215–26.
Salud. OOM de la. Estadísticas Sanitarias Mundiales 2013: Una Mina de Información sobre Salud Publica. 2013
Social EM protección. Analisis de la situación de salud Colombia ASIS. Minist Protección Soc. 2015
Mir I CL. Serum Biomarkers to evaluate the integrity of the neurovascular unit. Early Hum Dev. 2009;90(10):707–11.
Jacon J. KM et al. Etiologies of NICY deaths. Pediatrics. 2015;135(1):776–8.
Sarnat HB SM. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976;33:696–705.
Ennen CS, Huisman TA, Savage WJ, Northington FJ, Jennings JM, Everett AD et al. Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling. Am J Obs Gynecol. 2011;205(3):251–7.
Barkovich AJ, Miller SP, Bartha A et al. MRimaging,MRspectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy. AJNR Am J Neuroradiol. 2006;27:533-47.
Ramaswamy V, Horton J, Vandermeer B, Buscemi N, Miller S YJ. Systematic reviewof biomarkers of brain injury in term neonatal encephalopathy. Pediatr NeurolMar. 2009;40(3):215–26.
Shankaran S, Laptook AR, Ehrenkranz RA et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005;353:1574–84.
Savman K, Blennow M, Gustafson K, Tarkowski E HH. Cytokine response incerebrospinal fluid after birth asphyxia. Pedia Res Jun. 1998;43(6):746–51.
Imran N CL. Serum Biomarkers to evaluate the integrity of the neurovascular unit. Ear Hum Devel. 2014;90(10):707–11.
Mir IN, Steven Brown L, Rosenfeld CR CL. Placental clearance/synthesis of neurobiomarkers GFAP and UCH-L1 in healthy term neonates and those with moderate-severe neonatal encephalopathy. Pediatr Res. 2019
Douglas-Escobar M, Yang C, Bennett J, Shuster J, Theriaque D, Leibovici A et al. A pilot study of novel biomarkers in neonates with hypoxic-ischemic encephalopathy. Pediatr Res Dec. 2010;68(6):531–6.
Celtik C, Acunas B, Oner N PO. Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy. Brain Dev. 2004;26(6):398–402.
Thornberg E, Thiringer K, Hagberg H KI. Neuron specific enolase in asphyxiated newborns: association with encephalopathy and cerebral function monitor trace. Arch Dis Child Fetal Neonatal. 1995;72:39–42.
Gazzolo D, Marinoni E, Di Iorio R, Bruschettini M, Kornacka M, Lituania M et al. Urinary S100B protein measurements: A tool for the early identification of hypoxic-ischemic encephalopathy in asphyxiated full-term infants. Crit Care Med Jan. 2004;32(1):131–6.
Risso FM, Serpero LD, Zimmermann LJ, GavilanesAW, Frulio R, Michetti F et al. Urine S100 BB and A1B dimers are valuable predictors of adverse outcome in full-term asphyxiated infants. Acta Paediatr. 2013;102(10):e467-72.
Hu J, Ferreira A VEL. S100b induces neuronal death through nitric oxide reléase from astrocytes. J Neurochem. 1997;69:2294–301.
Murray DM. Biomarkers in neonatal hypoxic-ischemic encephalopathy-Review of the literature to date and future directions for research. hand clin neurol. 2019;162:281–93.
Sistema General de Seguridad Social en Salud M de S y de la PS. Republica de Colombia. Resolucion 8430 de 1993. Republica Ministerio de Salud. 1993. p. 1–19.
Welch V, Petticrew M, Tugwell P, Moher D, Neill JO, Waters E, et al. Extensión PRISMA-Equidad 2012 : guías para la escritura y la publicación de revisiones sistemáticas enfocadas en la equidad en salud *. Rev Panam Salud Pública. 2013;34(4):60–8.
Bersani I, Ferrari F, Lugli L, Ivani G, Conio A, Moataza B, Aboulgar H, Mufeed H, Iskander I, Kornacka M, Gruzfeld D, Dotta A, Savarese I CN et al. Monitoring the effectiveness of hypothermia in perinatal asphyxia infants by urinary S100B levels. Clin Chem Lab Med. 2019
Massaro AN1, Wu YW, Bammler TK, Comstock B, Mathur A, McKinstry RC, Chang T, Mayock DE MS et al. Plasma Biomarkers of Brain Injury in Neonatal Hypoxic-Ischemic Encephalopathy. J Pediatr. 2018
Alshweki A, Pérez-Muñuzuri A, López-Suárez O, Baña A CM. Relevance of urinary S100B protein levels as a short-term prognostic biomarker in asphyxiated infants treated with hypothermia. Med. 2017
Zaigham M, Lundberg F OP. Protein S100B in umbilical cord blood as a potential biomarker of hypoxic-ischemic encephalopathy in asphyxiated newborns. Early Hum Dev. 2017
Gazzolo D, Pluchinotta F, Bashir M, Aboulgar H, Said HM, Iman I, Ivani G, Conio A, Tina LG NF. Neurological abnormalities in full-term asphyxiated newborns and salivary S100B testing: the “Cooperative Multitask against Brain Injury of Neonates” (CoMBINe) international study. PLoS One. 2015
Chaparro-Huerta V, Flores-Soto ME, Merin Sigala ME, Barrera de León JC, Lemus-Varela ML, Torres-Mendoza BM B-ZC. Proinflammatory Cytokines, Enolase and S-100 as Early Biochemical Indicators of Hypoxic-Ischemic Encephalopathy Following Perinatal Asphyxia in Newborns. Pediatr Neonatol. 2017
Arca G, Arnaez J, Agut T, Núñez C, Stephan-Otto C, Valls A G-AA. Neuron-specific enolase is correlated with lesion topology, relative infarct volume and outcome of symptomatic NAIS. Arch Dis Child Fetal Neonatal Ed. 2020
JuanArnaezPhD CME-P ;Thais A. Neuron-Specific Enolase in Cerebrospinal Fluid Predicts Brain Injury After Sudden Unexpected Postnatal Collapse. Pediatr Neurol. 2019
Leifsdottir K1, 2, Mehmet H3, 4, Eksborg S1 HE. Fas-ligand and interleukin-6 in the cerebrospinal fluid are early predictors of hypoxic-ischemic encephalopathy and long-term outcomes after birth asphyxia in term infants. J Neuroinflammation. 2018
Patil UP, Mally PV WE. Serum biomarkers of neuronal injury in newborns evaluated for selective head cooling: a comparative pilot study. J Perinat Med. 2018
Ann-Marie Looney, Caroline Ahearne, Geraldine B. Boylan and DMM. Glial Fibrillary Acidic Protein Is Not an Early Marker of Injury in Perinatal Asphyxia and Hypoxic–Ischemic Encephalopathy. Front Neurol. 2015
Looney AM, O’Sullivan MP, Ahearne CE, Finder M, Felderhoff-Mueser, Boylan GB, Hallberg B MD. Altered Expression of Umbilical Cord Blood Levels of miR-181b and Its Downstream Target mUCH-L1 in Infants with Moderate and Severe Neonatal Hypoxic-Ischaemic Encephalopathy. Mol Neurobiol.
Kelen D, Andorka C, Szabó M1, Alafuzoff A Kaila K SM. Serum copeptin and neuron specific enolase are markers of neonatal distress and long-term neurodevelopmental outcome. PLoS One.
CE A. Short and long term prognosis in perinatal asphyxia: An update. World J Clin Pediatr. 2016;5(1):67.
Ahearne CE, Chang RY, Walsh BH, Boylan GB MD. Cord Blood IL-16 Is Associated with 3-Year Neurodevelopmental Outcomes in Perinatal Asphyxia. Dev Neurosci. 2017
Orrock JE, Panchapakesan K, Vezina G, Chang T, Harris K, Wang Y, Knoblach S MA. Association of brain injury and neonatal cytokine response during therapeutic hypothermia in newborns with hypoxic-ischemic encephalopathy. Pediatr Res. 2016
González-Losada, Cristóbal; Dorta-Contreras AJ. Marcadores moleculares de la asfixia perinatal / Molecular markers of perinatal asphyxia. Rev Cuba pediatr. 2018
Chalak Lina. Inflammatory Biomarkers Of Bith Asphyxia. Clin Perinatol. 2016; 43:501-510
Murray Dm. Biomarkers in neonatal hypoxic-ischemic encephalopathy-Review of the literature to date and future directions for research. Handb Clin Neurol. 2019;162:281-293.
González-Losada, Cristóbal; Dorta-Contreras, Alberto Juan. Marcadores moleculares de la asfixia perinatal / Molecular markers of perinatal asphyxia. Rev. cuba. Pediatr. 2018;90 (1)
Fisher P. In search of biomarkers for HIE. J. Pediatr. 2018: 194 (3).
Massaro A, Wu Y, Bammler T, Comstock B. Plasma Biomarkers Of Brain Injury in Neonatal Hypoyc –Ischemic Encephalopaty. J. Pediatric;2018: 194 (68)
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: La encefalopatía neonatal, secundaria a daño hipóxico isquémico durante el nacimiento tiene graves consecuencias, y hasta la fecha no está claro el papel de los marcadores tales como SB 100, GFAP, diferentes IL y la enolasa espec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5188401f308f62823854f99718a84b4